{"paper_id":"39c1ae94-278a-4636-8eb0-6b4039ac7859","body_text":"ECR 2022 / C-15758\nAdenomyosis: a cause of \"unexplained\" female infertility\nCongress:\nECR 2022\nPoster Number:\nC-15758\nType:\nScientific Exhibit\nKeywords:\nGenital / Reproductive system female, Pelvis, MR, Ultrasound, Ultrasound-Colour Doppler, Ablation procedures, Education, Localisation, Cancer, Pathology\nAuthors:\nH. Arbouni, H. hilal, H. E. azouazi, D. LAOUDIYI, K. CHBANI, S. SALAM, L. OUZIDANE\nDOI:\n10.26044/ecr2022/C-15758\nPurpose\nKnow how to recognize adenomyosis on imaging\nIdentify the pathologies that are frequently associated with it in order to guide the therapeutic management of symptomatic patients.\nTo know the role of adenomyosis in female infertility\nMethods and materials\nIt is a retrospective study on 30 patients\nLocation: Radiology department of the CHU Casablanca,\nPeriods: 3 years : (from February 2018 to February 2021)\nInclusion criteria: primary or secondary infertility associated with adenomyosis diagnosed by ultrasound and/or MRI\nResults\nThe average age was 41 years with extremes of age between 37 and 46 years\nOur patients had a history of: multiparity (20 cases); miscarriage (5 cases); myomectomy (7 cases) and breast cancer under Tamoxifen (3 cases)\nClinically, the patients had: primary or secondary infertility(25cases); metrorrhagia(20cases) and pelvic pain(20cases)\nThe radiological findings on ultrasound and MRI were: asymmetry of the myometrial walls (22 cases); thickening of the endometrial/myometrial junction of the endometrium/myometrium junction (20 cases); subendometrial microcysts (18 cases); heterogeneous appearance of the myometrium (18...\nConclusion\nAdenomyosis is related to the invagination of endometrial islets within the myometrium, leading to a disturbance of the contractile activity of the myometrium contractile activity of the latter, also potentiated by local hyperestrogenism.\nDiagnosis is based on imaging: ultrasound and MRI\nMedical and surgical treatments are disappointing, with the exception of GnRH agonists, which allow compensation in IVF/ICSI, which makes it possible to compensate for the implantation anomalies observed in this pathology.\nPersonal information and conflict of interest\nH. Arbouni:\nNothing to disclose\nH. hilal:\nNothing to disclose\nh. e. azouazi:\nNothing to disclose\nD. LAOUDIYI:\nNothing to disclose\nK. CHBANI:\nNothing to disclose\nS. SALAM:\nNothing to disclose\nL. OUZIDANE:\nNothing to disclose\nReferences\n1: Imaging features of adenomyosis Author links open overlay panelM.Bazot(Praticien hospitalier)aJ.Nassar-Slaba(Interne)aJ.Rouger(Attaché)aA.Cortez(Praticien hospitalier)bE.Daraï(Professeur des Universités, praticien hospitalier)\n2:Mise au point sur l’adénomyose - 10/01/13 Doi : 10.1016/j.jradio.2012.06.009 G. Levy a, ⁎ , A. Dehaene a, N. Laurent a, b, M. Lernout a, c, P. Collinet d, J.-P. Lucot d, C. Lions a, E. Poncelet a,","source_license":"CC0","license_restricted":false}